Kathleen Bowling
Family · Gaffney, SCNPI 1649789579
Payments from drug & device makers
Across 51 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$86
- Pfizer$83
- Amneal Pharmaceuticals LLC$63
- Biohaven Pharmaceuticals, Inc.$59
- Novo Nordisk$59
- Dexcom, Inc.$55
- plus $429 from 17 others
What the payments were for
- Food & beverage$834100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $86 |
| Pfizer | 6 | $83 |
| Amneal Pharmaceuticals LLC | 4 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Novo Nordisk | 4 | $59 |
| Dexcom, Inc. | 3 | $55 |
| Astellas Pharma US Inc | 3 | $53 |
| AstraZeneca | 3 | $49 |
| Boehringer Ingelheim | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| GSK | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $29 |
| Mylan Specialty L.p. | 1 | $24 |
| Inari Medical, Inc. | 1 | $22 |
| Merck | 1 | $19 |
| Bigfoot Biomedical Inc | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Novartis | 1 | $15 |
| Amgen | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
How this compares
$834 in reported general payments places this provider in the 60th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $20,985 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,631 |
| Rosuvastatin Calcium | 31 | $627 |
| Potassium Chloride | 21 | $541 |
| Atorvastatin Calcium | 69 | $504 |
| Lisinopril | 52 | $417 |
| Amlodipine Besylate | 56 | $366 |
| Famotidine | 15 | $360 |
| Olmesartan Medoxomil | 13 | $338 |
| Gabapentin | 33 | $316 |
| Duloxetine Hcl | 18 | $304 |
| Omeprazole | 32 | $301 |
| Pravastatin Sodium | 25 | $270 |
| Tamsulosin Hcl | 23 | $263 |
| Escitalopram Oxalate | 15 | $208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $59 | $20,98512 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $63 | $20732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,248 family providers in South Carolina.
Other family in Gaffney
- Tonya ReidGaffney$12K
- Melisa HammettGaffney$10K
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.